CS logo
small CS logo
Brigham and Women's Hospital - Infectious Diseases

Boston, Massachusetts, United States
Hospital department in Boston, Massachusetts
15 Francis St 2nd Floor, Boston, MA 02115

About Brigham and Women's Hospital - Infectious Diseases


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Brigham and Women's Hospital - Infectious Diseases


During the past decade, Brigham and Women's Hospital - Infectious Diseases conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 3 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Brigham and Women's Hospital - Infectious Diseases" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 2 trials as a collaborator, "Glaxo Wellcome" with 2 trials as a collaborator, "Biocine" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

Clinical Trials Conditions at Brigham and Women's Hospital - Infectious Diseases


According to Clinical.Site data, the most researched conditions in "Brigham and Women's Hospital - Infectious Diseases" are "HIV Infections" (6 trials), "COVID-19" (4 trials), "Pregnancy" (2 trials), "Cytomegalovirus Infection" (1 trials) and "HIV Seronegativity" (1 trials). Many other conditions were trialed in "Brigham and Women's Hospital - Infectious Diseases" in a lesser frequency.

Clinical Trials Intervention Types at Brigham and Women's Hospital - Infectious Diseases


Most popular intervention types in "Brigham and Women's Hospital - Infectious Diseases" are "Drug" (11 trials), "Biological" (7 trials) and "Other" (5 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Remdesivir" (3 trials), "Zidovudine" (3 trials), "Zalcitabine" (2 trials) and "AS03" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Brigham and Women's Hospital - Infectious Diseases


The vast majority of trials in "Brigham and Women's Hospital - Infectious Diseases" are 12 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at Brigham and Women's Hospital - Infectious Diseases


Currently, there are NaN active trials in "Brigham and Women's Hospital - Infectious Diseases". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Brigham and Women's Hospital - Infectious Diseases, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Brigham and Women's Hospital - Infectious Diseases, 4 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".